|
2025-06-16 |
2025-06-13 |
PS
Planned sale
|
Zanotti Katherine S
Non-Executive Director
|
1,000
-4.2%
53.20
USD 170,612
|
1,000
-4.2%
|
53.20
|
USD 100,000
|
|
|
2024-11-13 |
2024-11-13 |
B
Purchase
|
Conroy Kevin T
President and CEO
Executive Director
|
19,500
+1.8%
51.35
USD 1,001,325
|
19,500
+1.8%
|
51.35
|
USD 1,001,325
|
|
|
2024-10-09 |
2024-10-08 |
PS
Planned sale
|
Baranick Brian
EVP, GM, Precision Oncology
Officer
|
929
-6.8%
70.00
USD 65,030
|
929
-6.8%
|
70.00
|
USD 65,030
|
|
|
2024-09-19 |
2024-09-18 |
PS
Planned sale
|
Baranick Brian
EVP, GM, Precision Oncology
Officer
|
929
-6.4%
70.00
USD 65,030
|
929
-6.4%
|
70.00
|
USD 65,030
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Conroy Kevin T
President and CEO
Executive Director
|
1,155
-0.1%
60.15
USD 69,473
|
1,155
-0.1%
|
60.15
|
USD 69,473
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Conroy Kevin T
President and CEO
Executive Director
|
1,155
-0.1%
60.15
USD 69,473
|
1,155
-0.1%
|
60.15
|
USD 69,473
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Baranick Brian
EVP, GM., Precision Oncology
Officer
|
110
-0.8%
60.15
USD 6,617
|
110
-0.8%
|
60.15
|
USD 6,617
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Baranick Brian
EVP, GM., Precision Oncology
Officer
|
110
-0.8%
60.15
USD 6,617
|
110
-0.8%
|
60.15
|
USD 6,617
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
102
-0.7%
60.15
USD 6,135
|
102
-0.7%
|
60.15
|
USD 6,135
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
102
-0.7%
60.15
USD 6,135
|
102
-0.7%
|
60.15
|
USD 6,135
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
136
-1.1%
60.15
USD 8,180
|
136
-1.1%
|
60.15
|
USD 8,180
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Elliott Jeffrey Thomas
Chief Financial Officer
Officer
|
136
-1.1%
60.15
USD 8,180
|
136
-1.1%
|
60.15
|
USD 8,180
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
102
-0.1%
60.15
USD 6,135
|
102
-0.1%
|
60.15
|
USD 6,135
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
COWARD D SCOTT
Non-Executive Director
|
67
-0.1%
60.15
USD 4,030
|
67
-0.1%
|
60.15
|
USD 4,030
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Herriott James
SVP, General Counsel & Sec
Officer
|
30
-0.3%
60.15
USD 1,805
|
30
-0.3%
|
60.15
|
USD 1,805
|
|
|
2024-05-02 |
2024-05-01 |
PS
Planned sale
|
Cunningham Everett
Chief Commercial Officer
Officer
|
136
-0.3%
60.15
USD 8,180
|
136
-0.3%
|
60.15
|
USD 8,180
|
|
|
2024-04-03 |
2024-04-02 |
PS
Planned sale
|
Baranick Brian
EVP, GM., Precision Oncology
Officer
|
924
-6.6%
79.43
USD 73,393
|
924
-6.6%
|
79.43
|
USD 73,393
|
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
2,000
-2.7%
70.00
USD 140,000
|
2,000
-2.7%
|
70.00
|
USD 140,000
|
|
|
2024-04-01 |
2024-03-28 |
PS
Planned sale
|
Condella Sarah
EVP, Human Resources
Officer
|
2,000
-2.6%
70.00
USD 140,000
|
2,000
-2.6%
|
70.00
|
USD 140,000
|
|
|
2024-03-04 |
2024-03-01 |
PS
Planned sale
|
ORVILLE JACOB A
General Manager, Screening
Officer
|
2,154
-13.1%
59.32
USD 127,775
|
2,154
-13.1%
|
59.32
|
USD 127,775
|
|
